CYP19A1 and breast cancer: Furthermore, decreased levels of prostaglandins may also result in lower levels of oestrogens by downregulating aromatase, an enzyme involved in converting androgen to oestrogen in peripheral fat tissue, and consequently a reduction in the risk of oestrogen receptor-positive (ER +) BC [5, 6].